Allogeneic HCT Using Conditioning Regimen of BuFluATG for AML CR1

Clinical trial NCT07155382 · COMPLETED

Trial details

NCT number: NCT07155382
Sponsor: Asan Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia (AML)

Start date: 2017-04-04
Primary completion: 2024-05-27
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.